2015
DOI: 10.1136/bmjopen-2014-007280
|View full text |Cite
|
Sign up to set email alerts
|

An investigation into the therapeutic effects of statins with metformin on polycystic ovary syndrome: a meta-analysis of randomised controlled trials

Abstract: ObjectivesTo investigate the therapeutic effects of statins with metformin on polycystic ovary syndrome (PCOS).SettingsEndocrinology department.ParticipantsMEDLINE, EMBASE and Cochrane Central Register of Controlled Trials were searched until October 2014. Studies comparing statins and placebo, as well as the combination of statins and metformin and metformin alone, were included in the analysis.InterventionsData were independently extracted by two researchers; any convergence was resolved by a third reviewer.… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
3
1
1

Citation Types

1
45
0
1

Year Published

2015
2015
2023
2023

Publication Types

Select...
6
1

Relationship

0
7

Authors

Journals

citations
Cited by 35 publications
(47 citation statements)
references
References 35 publications
1
45
0
1
Order By: Relevance
“…Seven reviews (n = 3 comparing metformin vs thiazolidinediones, n = 2 comparing metformin vs placebo, n = 1 comparing metformin vs COCPs and n = 1 comparing combination therapy with metformin and clomiphene citrate vs clomiphene citrate alone) reported results favouring metformin in terms of BMI and/or waist‐hip ratio. There was no significant difference in anthropometric outcomes when metformin was compared to acarbose or orlistat, or when combination therapy with metformin and statin was compared to metformin alone . Endocrine outcomes were assessed by 12 reviews.…”
Section: Resultsmentioning
confidence: 99%
See 3 more Smart Citations
“…Seven reviews (n = 3 comparing metformin vs thiazolidinediones, n = 2 comparing metformin vs placebo, n = 1 comparing metformin vs COCPs and n = 1 comparing combination therapy with metformin and clomiphene citrate vs clomiphene citrate alone) reported results favouring metformin in terms of BMI and/or waist‐hip ratio. There was no significant difference in anthropometric outcomes when metformin was compared to acarbose or orlistat, or when combination therapy with metformin and statin was compared to metformin alone . Endocrine outcomes were assessed by 12 reviews.…”
Section: Resultsmentioning
confidence: 99%
“…The country of origin of the authors included China (n = 11), [29][30][31][32][33][34][35][36][37][38][39] Australia (n = 6), [40][41][42][43][44][45] United Kingdom (n = 5), 43,[45][46][47][48] the United States of America (n = 4), [49][50][51][52] India (n = 3), 44,52,53 Canada (n = 3), 50,54,55 Brazil (n = 2), 41,56 Iran (n = 2), 40,54 Columbia (n = 1), 46 Greece (n = 1), 57 Italy (n = 1), 57 Spain (n = 1), 58 Scotland (n = 1), 59 Luton (n = 1), 48 Netherlands (n = 1) 41 and Saudi Arabia (n = 1). 46 Thirteen reviews explicitly included randomized control trials (RCTs) only [29][30][31][32]34,36,38,42,43,…”
Section: Study Characteristicsmentioning
confidence: 99%
See 2 more Smart Citations
“…There are a few studies of statin therapy in women with PCOS with lipid abnormalities replicating this finding. [144,145] The additional benefits of statins include a reduction of ovarian androgen synthesis as noted by a study of atorvastatin on metabolic profile of women with PCOS. [146]…”
Section: Novel Therapeutic Targets For Pcos With Mbsmentioning
confidence: 99%